ArticleThe journal of nutrition, health & aging2011
IAGG workshop: health promotion program on prevention of late onset dementia.
Article in The journal of nutrition, health & aging, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01306695 (Comparative Effectiveness of the NYU Caregiver Intervention in Latinos in Northern Manhattan), which is not on this map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparative Effectiveness of the NYU Caregiver Intervention in Latinos in Northern Manhattan
Who cites it
12 citing papers in PubMed, 32 citations in OpenAlex.
- Ghrelin, Amylin, Gastric Inhibitory Peptide and Cognition in Middle-Aged HIV-Infected and Uninfected Women: The Women's Interagency HIV Study.Journal of neurology & neurophysiology · 2017Article
- First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia.Journal of translational medicine · 2016Article
- Towards a comprehensive public health response to population ageing.Lancet (London, England) · 2015Article
- The recent decline in prevalence of dementia in developed countries: implications for prevention in the Republic of Korea.Journal of Korean medical science · 2014Article
- MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA.The journal of prevention of Alzheimer's disease · 2014Article
- Anthropometric measures and cognition in middle-aged HIV-infected and uninfected women. The Women's Interagency HIV Study.Journal of neurovirology · 2013Article
- Nonpharmacologic treatment and prevention strategies for dementia.Continuum (Minneapolis, Minn.) · 2013Review
- Current evidence for the clinical use of long-chain polyunsaturated n-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease.The journal of nutrition, health & aging · 2013Article
- Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease.The journal of nutrition, health & aging · 2012Article
- Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology.The journal of nutrition, health & aging · 2012Article
- Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial).The journal of nutrition, health & aging · 2012Article
- Dementia prevention: current epidemiological evidence and future perspective.Alzheimer's research & therapy · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
28 authors at 20 institutions in 16 countries.
Funding
Abstract
IAGG, WHO, and SFGG organized a international workshop on Health promotion programs on prevention of late on-set dementia. Thirty world specialists coming from Europe, North America, Asia, South America, Africa and Australia, shared their experience on methods and results of large epidemiological interventions to reduce incidents of dementia or delay its on-set. Chaired by Laura FRATIGLIONI, an expert in Epidemiological studies on dementia issues, the workshop gave opportunity for discussions and controversies about the state-of-the-art. Based on different national and international trials (ADAPT, MAPT, FINGER, GUDIAGE, GEM etc) the questions remained opened for different aspects of methodology, the choice of domain or multi domain intervention, the choice and the definition of the target populations, the best age of candidates, the issues related to the discrepancy between late effects, and interventions' duration. We are please to publish in the Journal, the presentations presented to this workshop. These publications will complete previously task force published in the journal in the last two years on methodological issues for Alzheimer's trials including end point, biomarkers, and the experience of past therapeutic trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.